Our strategy

We aim to deliver consistent and profitable growth by putting better health within reach every day, creating high-quality medicines and making them accessible for patients around the world.

Strive for excellence
We will strengthen and enhance our business, while ensuring that quality remains at the heart of everything we do. Leveraging our strong commercial platforms to maximise the potential of our broad product portfolio. Expanding our manufacturing capabilities with a focus on adding new technologies. Optimising operational efficiencies.
Diversify and differentiate
We will continue to add differentiation to our pipeline through increased investment in our R&D capabilities. We will seek out partnerships and acquisitions, adding complex products complementary to our in-house pipeline and portfolio. We will also continue to expand selectively into adjacent businesses and geographies.
People and responsibility
The dedication and commitment of our people drives our strategy. We want to empower our people to do their best work and provide opportunities for everyone to thrive. Operating responsibly, we will also remain focused on advancing health and wellbeing, protecting the environment, and building trust through quality in everything we do.

Latest stories

Decorative image.

Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...

Press Release, Business Development 12 February 2024
Related content

Explore more